Literature DB >> 2168693

High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis.

K Nagasawa1, Y Yamauchi, Y Tada, T Kusaba, Y Niho, H Yoshikawa.   

Abstract

The incidence of herpes zoster was determined in patients with systemic lupus erythematosus (SLE) and the cellular and humoral immunity to varicella zoster virus (VZV) investigated in 45 of these 92 patients. The incidence of herpes zoster was high, occurring in 40 patients (43%), though it was benign in all. Patients with SLE who had had zoster showed significantly higher antibody titres than normal subjects. On the other hand, only 13 of 43 (30%) patients with SLE showed positive delayed hypersensitivity skin reactions to VZV antigen, despite a history of infections with VZV, whereas all 15 normal subjects had positive reactions. Skin reactions to VZV correlated directly with the ratio of OKT4+ to OKT8+ T cells and inversely with the dose of corticosteroids. These results suggest that the high incidence of herpes zoster in patients with SLE is probably due to defects in cellular immunity and that normal or higher titres of antibodies to VZV will not act as a preventive against zoster. In addition, reactivation of VZV, whether symptomatic or not, seemed often to occur in patients with SLE.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168693      PMCID: PMC1004180          DOI: 10.1136/ard.49.8.630

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

1.  CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES.

Authors:  E L DUBOIS; D L TUFFANELLI
Journal:  JAMA       Date:  1964-10-12       Impact factor: 56.272

2.  THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS.

Authors:  R E HOPE-SIMPSON
Journal:  Proc R Soc Med       Date:  1965-01

3.  The natural history of herpes zoster.

Authors:  C F BURGOON; J S BURGOON; G D BALDRIDGE
Journal:  J Am Med Assoc       Date:  1957-05-18

4.  NIH conference. Herpes zoster-varicella infections in immunosuppressed patients.

Authors:  R Dolin; R C Reichman; M H Mazur; R J Whitley
Journal:  Ann Intern Med       Date:  1978-09       Impact factor: 25.391

5.  Abnormalities of delayed hypersensitivity in systemic lupus erythematosus.

Authors:  B H Hahn; K K Bagby; C K Osterland
Journal:  Am J Med       Date:  1973-07       Impact factor: 4.965

6.  Lupus erythematosus and herpes zoster.

Authors:  T Hamaguchi; Y Kotani; S Imanaka; S Morito; Y Kawamura
Journal:  Mie Med J       Date:  1970-01

7.  Immune responses to varicella-zoster in the aged.

Authors:  B L Burke; R W Steele; O W Beard; J S Wood; T D Cain; D J Marmer
Journal:  Arch Intern Med       Date:  1982-02

Review 8.  Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1983-12-01       Impact factor: 91.245

9.  Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma.

Authors:  A M Arvin; R B Pollard; L E Rasmussen; T C Merigan
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

10.  Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus.

Authors:  E Ginzler; H Diamond; D Kaplan; M Weiner; M Schlesinger; M Seleznick
Journal:  Arthritis Rheum       Date:  1978 Jan-Feb
View more
  21 in total

1.  Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study.

Authors:  Valentin S Schäfer; Tanaz A Kermani; Cynthia S Crowson; Gene G Hunder; Sherine E Gabriel; Steven R Ytterberg; Eric L Matteson; Kenneth J Warrington
Journal:  Rheumatology (Oxford)       Date:  2010-07-13       Impact factor: 7.580

2.  Longitudinal analysis of varicella-zoster virus-specific antibodies in systemic lupus erythematosus: No association with subclinical viral reactivations or lupus disease activity.

Authors:  C Rondaan; C C van Leer; S van Assen; H Bootsma; K de Leeuw; S Arends; N A Bos; J Westra
Journal:  Lupus       Date:  2018-04-18       Impact factor: 2.911

3.  The case for Zostavax vaccination in systemic lupus erythematosus.

Authors:  Abigail R Cogman; Eliza F Chakravarty
Journal:  Vaccine       Date:  2013-06-03       Impact factor: 3.641

4.  Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis.

Authors:  Candace H Feldman; Linda T Hiraki; Wolfgang C Winkelmayer; Francisco M Marty; Jessica M Franklin; Seoyoung C Kim; Karen H Costenbader
Journal:  Arthritis Rheumatol       Date:  2015-06       Impact factor: 10.995

Review 5.  Vaccination of patients with autoimmune inflammatory rheumatic diseases.

Authors:  Johanna Westra; Christien Rondaan; Sander van Assen; Marc Bijl
Journal:  Nat Rev Rheumatol       Date:  2014-12-09       Impact factor: 20.543

6.  Carbamazepine-Induced Stevens-Johnson Syndrome Sparing the Skin Previously Affected by Herpes Zoster Infection in a Patient with Systemic Lupus Erythematosus: A Reverse Isotopic Phenomenon.

Authors:  Daniela Tenea
Journal:  Case Rep Dermatol       Date:  2010-08-09

7.  Cutaneous warts in patients with lupus erythematosus.

Authors:  Cengiz Korkmaz; S Murat Urer
Journal:  Rheumatol Int       Date:  2003-09-11       Impact factor: 2.631

Review 8.  Lupus nephritis in childhood and adolescence.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

9.  Herpes Zoster Infections in SLE in a University Hospital in Saudi Arabia: Risk Factors and Outcomes.

Authors:  Afsar Sayeeda; Hussain Al Arfaj; Najma Khalil; A S Al Arfaj
Journal:  Autoimmune Dis       Date:  2010-09-13

10.  Clinical and genetic risk factors of herpes zoster in patients with systemic lupus erythematosus.

Authors:  Tae-Young Kang; Hye-Soon Lee; Tae-Hwan Kim; Jae-Bum Jun; Dae-Hyun Yoo
Journal:  Rheumatol Int       Date:  2003-10-31       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.